全文获取类型
收费全文 | 2719篇 |
免费 | 144篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 108篇 |
妇产科学 | 29篇 |
基础医学 | 332篇 |
口腔科学 | 81篇 |
临床医学 | 186篇 |
内科学 | 479篇 |
皮肤病学 | 58篇 |
神经病学 | 188篇 |
特种医学 | 308篇 |
外国民族医学 | 1篇 |
外科学 | 432篇 |
综合类 | 68篇 |
预防医学 | 112篇 |
眼科学 | 36篇 |
药学 | 221篇 |
中国医学 | 3篇 |
肿瘤学 | 225篇 |
出版年
2023年 | 14篇 |
2022年 | 41篇 |
2021年 | 65篇 |
2020年 | 37篇 |
2019年 | 54篇 |
2018年 | 47篇 |
2017年 | 38篇 |
2016年 | 54篇 |
2015年 | 70篇 |
2014年 | 68篇 |
2013年 | 114篇 |
2012年 | 161篇 |
2011年 | 171篇 |
2010年 | 105篇 |
2009年 | 124篇 |
2008年 | 175篇 |
2007年 | 154篇 |
2006年 | 152篇 |
2005年 | 124篇 |
2004年 | 144篇 |
2003年 | 110篇 |
2002年 | 100篇 |
2001年 | 27篇 |
2000年 | 22篇 |
1999年 | 46篇 |
1998年 | 67篇 |
1997年 | 71篇 |
1996年 | 63篇 |
1995年 | 54篇 |
1994年 | 45篇 |
1993年 | 48篇 |
1992年 | 24篇 |
1991年 | 26篇 |
1990年 | 29篇 |
1989年 | 33篇 |
1988年 | 34篇 |
1987年 | 29篇 |
1986年 | 26篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1983年 | 11篇 |
1982年 | 22篇 |
1981年 | 6篇 |
1980年 | 14篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1975年 | 4篇 |
1968年 | 3篇 |
排序方式: 共有2889条查询结果,搜索用时 15 毫秒
1.
2.
3.
Y K Murali P Anand V Tandon R Singh R Chandra P S Murthy 《Experimental and clinical endocrinology & diabetes》2007,115(10):641-646
The aqueous extract of the fruits of Terminalia chebula Retz. has been evaluated for its antidiabetic activity in streptozotocin (STZ) induced mild diabetic rats and compared with a known drug, tolbutamide. The oral effective dose (ED) of the extract was observed to be 200 mg/kg body weight, which produced a fall of 55.6% (p<0.01) in the oral glucose tolerance test. Oral administration of ED of aqueous extract of T.chebula (AETC) daily once for two months reduced the elevated blood glucose by 43.2% (p<0.01) and significantly reduced the increase in glycosylated hemoglobin (HbA1c) (p<0.01). The same dose also showed a marked improvement in controlling the elevated blood lipids as well as decreased serum insulin levels in contrast to the untreated diabetic animals. Hepatic and skeletal muscle glycogen content decreased by 75% and 62.9% respectively in diabetic controls, these alterations were partly prevented (34.9% and 21.17%) in AETC treated group when compared to the healthy controls. The in vitro studies with pancreatic islets showed that the insulin release was nearly two times more than that in untreated diabetic animals. The treatment did not have any unfavorable effect on other blood parameters of liver and kidney function tests. LD 50 was found to be above 3 g/kg bw i.e. 15 times of ED, because there were no deaths of animals even at this dose indicating high margin of safety. These findings suggest further investigations for the possible use of the aqueous extract of fruits of T.chebula for the treatment of diabetes. 相似文献
4.
5.
6.
7.
8.
Mohan Kameshwaran Dilip Raghavan R. S. Anand Kumar Sathiya Murali 《Indian journal of otolaryngology and head and neck surgery》2006,58(3):229-231
Oral Submucous Fibrosis is an insidious, chronic disease affecting the oral cavity, sometimes the pharynx and rarely the tongue. 15 patients with Oral Submucous Fibrosis presenting with severe trismus were treated with lysis of the fibrotic bands with a KTP-532 Laser and adjunctive treatment with excellent results over a 12 month follow-up period. 相似文献
9.
S. van Ruth† EBL van Dorst‡ MR Canninga-van Dijk§ MS de Bruin-Weller† 《Journal of the European Academy of Dermatology and Venereology》2007,21(5):678-680
Cutaneous metastasis of vaginal carcinoma is extremely rare. So far, the total number of reported skin metastasis of vaginal carcinoma is only one. We present another case with an unusual manifestation of vagina carcinoma metastasis: skin metastasis presenting as a leg ulcer on the lower leg. 相似文献
10.
Anthony P. Khalifah Ramsey R. Hachem Murali M. Chakinala Roger D. Yusen Aviva Aloush G. Alexander Patterson Thalachallour Mohanakumar Elbert P. Trulock Michael J. Walter 《American journal of transplantation》2005,5(8):2022-2030
Bronchiolitis obliterans syndrome (BOS) is a major cause of lung allograft dysfunction. Although previous studies have identified mild to severe rejection (grade>or=A2) as a risk factor for BOS, the role of minimal rejection (grade A1) remains unclear. To determine if A1 rejection by itself is a risk factor for BOS, we performed a retrospective cohort study on 228 adult lung transplant recipients over a 7-year period. Cohorts were defined by their most severe rejection episode (none, A1 only, and >or=A2) and analyzed for the subsequent development and progression of BOS using univariate and multivariate time-dependent Cox regression analysis. In the univariate model, the occurrence of isolated minimal rejection was a risk factor for all stages of BOS. Similarly, multivariate models that included HLA mismatch, cytomegalovirus pneumonitis, community acquired viral infection, underlying disease and type of transplant demonstrated that A1 rejection was a distinct risk factor for BOS. Furthermore, the associated risk with A1 rejection was slightly greater than the risk from >or=A2 and treatment of A1 rejection decreased the risk for subsequent BOS stage 1. We conclude that minimal rejection is associated with an increased risk for BOS development and progression that is comparable to A2 rejection. 相似文献